142 related articles for article (PubMed ID: 27084712)
1. The glycation of fibronectin by glycolaldehyde and methylglyoxal as a model for aging in Bruch's membrane.
Thao MT; Gaillard ER
Amino Acids; 2016 Jul; 48(7):1631-9. PubMed ID: 27084712
[TBL] [Abstract][Full Text] [Related]
2. Modifications to the basement membrane protein laminin using glycolaldehyde and A2E: a model for aging in Bruch's membrane.
Murdaugh LS; Dillon J; Gaillard ER
Exp Eye Res; 2009 Aug; 89(2):187-92. PubMed ID: 19358843
[TBL] [Abstract][Full Text] [Related]
3. A2E-mediated photochemical modification to fibronectin and its implications to age-related changes in Bruch's membrane.
Thao MT; Renfus DJ; Dillon J; Gaillard ER
Photochem Photobiol; 2014; 90(2):329-34. PubMed ID: 24303925
[TBL] [Abstract][Full Text] [Related]
4. Development of a polyclonal antibody with broad epitope specificity for advanced glycation endproducts and localization of these epitopes in Bruch's membrane of the aging eye.
Farboud B; Aotaki-Keen A; Miyata T; Hjelmeland LM; Handa JT
Mol Vis; 1999 Jul; 5():11. PubMed ID: 10407062
[TBL] [Abstract][Full Text] [Related]
5. Increase in the advanced glycation end product pentosidine in Bruch's membrane with age.
Handa JT; Verzijl N; Matsunaga H; Aotaki-Keen A; Lutty GA; te Koppele JM; Miyata T; Hjelmeland LM
Invest Ophthalmol Vis Sci; 1999 Mar; 40(3):775-9. PubMed ID: 10067983
[TBL] [Abstract][Full Text] [Related]
6. Advanced glycation end product (AGE) accumulation on Bruch's membrane: links to age-related RPE dysfunction.
Glenn JV; Mahaffy H; Wu K; Smith G; Nagai R; Simpson DA; Boulton ME; Stitt AW
Invest Ophthalmol Vis Sci; 2009 Jan; 50(1):441-51. PubMed ID: 18676633
[TBL] [Abstract][Full Text] [Related]
7. Peptide mapping identifies hotspot site of modification in human serum albumin by methylglyoxal involved in ligand binding and esterase activity.
Ahmed N; Dobler D; Dean M; Thornalley PJ
J Biol Chem; 2005 Feb; 280(7):5724-32. PubMed ID: 15557329
[TBL] [Abstract][Full Text] [Related]
8. Confocal Raman microscopy can quantify advanced glycation end product (AGE) modifications in Bruch's membrane leading to accurate, nondestructive prediction of ocular aging.
Glenn JV; Beattie JR; Barrett L; Frizzell N; Thorpe SR; Boulton ME; McGarvey JJ; Stitt AW
FASEB J; 2007 Nov; 21(13):3542-52. PubMed ID: 17567569
[TBL] [Abstract][Full Text] [Related]
9. Overexpression of integrin alpha6 and beta4 enhances adhesion and proliferation of human retinal pigment epithelial cells on layers of porcine Bruch's membrane.
Fang IM; Yang CH; Yang CM; Chen MS
Exp Eye Res; 2009 Jan; 88(1):12-21. PubMed ID: 18955047
[TBL] [Abstract][Full Text] [Related]
10. Detection of oxidized and glycated proteins in clinical samples using mass spectrometry--a user's perspective.
Thornalley PJ; Rabbani N
Biochim Biophys Acta; 2014 Feb; 1840(2):818-29. PubMed ID: 23558060
[TBL] [Abstract][Full Text] [Related]
11. Reattachment of cultured human retinal pigment epithelium to extracellular matrix and human Bruch's membrane.
Ho TC; Del Priore LV
Invest Ophthalmol Vis Sci; 1997 May; 38(6):1110-8. PubMed ID: 9152230
[TBL] [Abstract][Full Text] [Related]
12. Chemical modification of proteins by methylglyoxal.
Degenhardt TP; Thorpe SR; Baynes JW
Cell Mol Biol (Noisy-le-grand); 1998 Nov; 44(7):1139-45. PubMed ID: 9846896
[TBL] [Abstract][Full Text] [Related]
13. Bruch's membrane aging decreases phagocytosis of outer segments by retinal pigment epithelium.
Sun K; Cai H; Tezel TH; Paik D; Gaillard ER; Del Priore LV
Mol Vis; 2007 Dec; 13():2310-9. PubMed ID: 18199972
[TBL] [Abstract][Full Text] [Related]
14. Peptide mapping of human serum albumin modified minimally by methylglyoxal in vitro and in vivo.
Ahmed N; Thornalley PJ
Ann N Y Acad Sci; 2005 Jun; 1043():260-6. PubMed ID: 16037246
[TBL] [Abstract][Full Text] [Related]
15. Effect of Cu(ii) on in vitro glycation of human serum albumin by methylglyoxal: a LC-MS-based proteomic approach.
Ramirez Segovia AS; Wrobel K; Acevedo Aguilar FJ; Corrales Escobosa AR; Wrobel K
Metallomics; 2017 Feb; 9(2):132-140. PubMed ID: 28001159
[TBL] [Abstract][Full Text] [Related]
16. Advanced glycation endproducts in food and their effects on health.
Poulsen MW; Hedegaard RV; Andersen JM; de Courten B; Bügel S; Nielsen J; Skibsted LH; Dragsted LO
Food Chem Toxicol; 2013 Oct; 60():10-37. PubMed ID: 23867544
[TBL] [Abstract][Full Text] [Related]
17. Glycation of low-density lipoproteins by methylglyoxal and glycolaldehyde gives rise to the in vitro formation of lipid-laden cells.
Brown BE; Dean RT; Davies MJ
Diabetologia; 2005 Feb; 48(2):361-9. PubMed ID: 15660260
[TBL] [Abstract][Full Text] [Related]
18. Stimulatory effects of advanced glycation endproducts (AGEs) on fibronectin matrix assembly.
Pastino AK; Greco TM; Mathias RA; Cristea IM; Schwarzbauer JE
Matrix Biol; 2017 May; 59():39-53. PubMed ID: 27425255
[TBL] [Abstract][Full Text] [Related]
19. The expression of advanced glycation endproduct receptors in rpe cells associated with basal deposits in human maculas.
Yamada Y; Ishibashi K; Ishibashi K; Bhutto IA; Tian J; Lutty GA; Handa JT
Exp Eye Res; 2006 May; 82(5):840-8. PubMed ID: 16364296
[TBL] [Abstract][Full Text] [Related]
20. Mass Spectrometric Analysis of Glyoxal and Methylglyoxal-Induced Modifications in Human Hemoglobin from Poorly Controlled Type 2 Diabetes Mellitus Patients.
Chen HJ; Chen YC; Hsiao CF; Chen PF
Chem Res Toxicol; 2015 Dec; 28(12):2377-89. PubMed ID: 26517015
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
